India to Saudi Arabia: Meropenem Export Trade Route

The India to Saudi Arabia Meropenem corridor is one of India's established pharmaceutical export routes, with 195 shipments documented worth a combined $11.0M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's meropenem manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $56.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with meropenem's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 11.3%, placing it at rank #11 among India's top meropenem export destinations globally.

On the import side, key buyers of Indian meropenem in Saudi Arabia include S T C, SALEHIYA TRADING COMPANY , S T C SALEHIYA TRADING and 6 others. S T C is the single largest importer with 95 shipments valued at $4.4M USD.

India's meropenem exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 137 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED , VENUS REMEDIES LTD — together account for 100% of total trade value on this route. The average shipment value of $56.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as meropenem 1.0 gm powder for solution forinjection or infusion ronem 1000mg and ronem 1.0 gm meropenem 1000mg powder for solution for injection or infusion each vial contains: active pharmaceutical, suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, S T C is the largest importer with 95 shipments worth $4.4M USD — representing 40% of all meropenem imports from India on this route. A total of 9 buyers are active on this corridor.